Domain Surgical Receives CE Mark Approval for FMwand Ferromagnetic Surgical System

Domain Surgical, a leading developer of advanced thermal surgical technology, today announced that it has received CE Mark approval for its FMwand Ferromagnetic Surgical System.
 
 
Spread the Word
Listed Under

Tags:
* Fmwand
* ce
* Europe
* Surgery

Industrys:
* Medical
* Manufacturing

Location:
* Salt Lake City - Utah - US

Subject:
* Awards

Feb. 6, 2013 - PRLog -- Domain Surgical, a leading developer of advanced thermal surgical technology, today announced that it has received CE Mark approval for its FMwand Ferromagnetic Surgical System. The FMwand is a hemostatic dissection device that uses thermal energy to cut and coagulate tissue, without passing an electrical current through the patient.

Apart from the FDA clearance, which was achieved in 2011, CE Marking indicates that Domain Surgical's design and manufacturing processes for the FMwand Ferromagnetic Surgical System comply with certain manufacturing and design standards under the European directive concerning medical devices. This certification enables Domain Surgical to commercialize the FMwand in Europe.

In order to receive the CE Mark, safety testing and a thorough review of the FMwand design was performed by the British Standards Institute (BSI). BSI is one of the world's most respected and comprehensive Notified Bodies with unrivaled expertise and experience in assisting its customers with regulatory and quality requirements for medical devices.

"The CE Mark approval is an important achievement in the growth of our company," said David McNally, President and CEO of Domain Surgical. "The effectiveness of the FMwand has been validated in our successful surgeries in the United States, and we are excited to now bring the unique surgical benefits of the FMwand to the European market."

The FMwand is a hemostatic dissection device that uses thermal energy to cut and coagulate tissue, without passing an electrical current through the patient. Because the FMwand cuts and coagulates with pure thermal energy, it has been shown to be safe and effective for dissecting around delicate tissues and structures such as nerves and blood vessels. The FMwand minimizes collateral tissue damage, causing as little as 1/10th the depth of thermal damage compared to standard electrocautery in some tissue types, preserving more viable, healthy tissue beyond the incisional plane.

About Domain Surgical, Inc.
Domain Surgical is a privately held company based in Salt Lake City, Utah. The company has commercialized a product line of capital equipment and single-patient-use disposables designed to address the known shortcomings of leading energy-based surgical equipment. Domain Surgical's patented technology produces surface-only tissue effects without passing electrical energy through the patient, and is designed with simple user interface for ease of use by the surgical staff. For more information, please visitwww.domainsurgical.com.
End
Source:
Email:***@domainsurgical.com Email Verified
Phone:801-924-4950
Zip:84108
Tags:Fmwand, ce, Europe, Surgery
Industry:Medical, Manufacturing
Location:Salt Lake City - Utah - United States
Subject:Awards
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Domain Surgical, Inc. News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share